Knight Therapeutics | GUD - Interest Expense On Debt

Stock Price
5.96
Daily Change
0.04 0.68%
Monthly
1.71%
Yearly
7.39%
Q1 Forecast
5.66

Knight Therapeutics reported CAD2.37M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Aurora Cannabis CAD 2.22M 442K Sep/2025
Avita Medical AUD 1.25M 100K Jun/2025
Canopy Growth CAD 8.8M 938K Sep/2025
Cronos Group USD 0 7K Sep/2024
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
IQVIA Holdings USD 189M 7M Sep/2025
Knight Therapeutics CAD 2.37M 6K Sep/2025
Moderna USD 12.14B 12.13B Sep/2025
Organon & Co USD 128M 3M Sep/2025
Revvity USD 22.77M 166K Sep/2025
Tectonic Therapeutic USD 277M 276.98M Sep/2025
Tilray USD 6.7M 2.73M Jun/2025
Viatris USD 119.6M 3M Sep/2025
Xeris Pharmaceuticals USD 7.27M 92K Sep/2025